Registration is open! 2nd How to Diagnose and Treat CML / MPN

December 15, 2020

2nd How to Diagnose and Treat
CML / MPN

February 25-28, 2021
E-CONFERENCE - #ESHCMLMPN2021
FREE REGISTRATION!

Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa

DEADLINE FOR ABSTRACTS AND CLINICAL CASES:
JANUARY 5th, 2021

ABOUT THE E-CONFERENCE:

In view of continuing COVID-19 related challenges and uncertainties, ESH has decided to hold the conference How to Diagnose and Treat CML / MPN as a virtual event. The registration is offered for free, as a gesture of solidarity during these difficult times.

An outstanding faculty of distinguished global experts will present the most recent advances and new perspectives in the field of CML and MPN.

The plenary E-Conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for scientific discussion and interaction.

Registered participants will further benefit from opportunities for informal scientific interaction with the world’s leading experts in the field during closed Meet the Experts sessions and E-Mentored Posters Walks.

PROGRAMME SUMMARY:
This second meeting organized by ESH to focus in depth upon the clinical management of patients with chronic myeloid leukemia and the myeloproliferative neoplasms, builds on the experiences and scientific progress since the highly successful Inaugural “How to Treat CML and MPN” held in Dublin in March 2019. This “ 2nd How to Diagnose and Treat CML and MPN” uses a case-based format to scrutinise with experts in the field relevant issues in diagnosis, prognostication, therapy selection, efficacy assessment, and management of toxicities for these patients. The format for this meeting will be highly interactive with a mixture of case-based didactic lectures, roundtable discussions regarding challenging clinical scenarios, and debates on controversial areas of management.
This first ESH meeting for MPN occurring since the onset of the COVID19 Pandemic will cover the specific patient implications for CML and MPN patients. The faculty for this event represent the clinical and scientific leaders of the MPN community from around the world and we anticipate great opportunities for interactions and discussions. Clinical haematologists, hematology nurses, clinician scientists, hematology investigators, and those in training will find great value in attending and participating in this event.

MAIN TOPICS:
- Optimizing cytoreduction - Management of CML with TKI
- MPN risk stratification including vascular events
- Evolving therapies in Myelofibrosis
- Management of advanced disease (MPN and CML)
- Treatment free remission in CML

TO ACCESS THE UPDATED PROGRAMME CLICK HERE

TO MEET THE FACULTY CLICK HERE

MORE INFORMATION

With the support of*: